Electrophoretic mobility shift assay (EMSA) with TCF/LEF probes revealed a concentration-dependent decrease in nuclear β-catenin in Tenovin-6-treated ALL cells (Figure 6D). This evidence concerns the gene HNF4A and acute lymphoblastic leukemia.